Mazzaschi, G.
45  results:
Search for persons X
?
2

Resistance to osimertinib in advanced EGFR-mutated NSCLC: a..:

Leonetti, A. ; Verzè, M. ; Minari, R....
British Journal of Cancer.  130 (2023)  1 - p. 135-142 , 2023
 
?
4

5P Blood immune-inflammatory dynamic unveils distinctive ir..:

Mazzaschi, G. ; Barbieri, M. ; Monica, G....
Immuno-Oncology and Technology.  20 (2023)  - p. 100476 , 2023
 
?
 
?
 
?
7

238P Exploring blood immune cell dynamics to unravel the im..:

Mazzaschi, G. ; Tamarozzi, P. ; Lorusso, B....
Immuno-Oncology and Technology.  16 (2022)  - p. 100227 , 2022
 
?
 
?
10

P-155SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSME..:

Quaini, F ; Bocchialini, Giovanni ; Mazzaschi, G...
Interactive CardioVascular and Thoracic Surgery.  25 (2017)  suppl_1 - p. , 2017
 
?
11

F-066BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL CO..:

Quaini, Federico ; Armani, G ; Madeddu, D...
Interactive CardioVascular and Thoracic Surgery.  25 (2017)  suppl_1 - p. , 2017
 
?
12

Modulating Tumor Microenvironment: A Review on STK11 Immune..:

Mazzaschi G ; Leonetti A ; Minari R...
info:eu-repo/semantics/altIdentifier/wos/WOS:000696198000004.  , 2021
 
?
13

PD-L1 SNPs as biomarkers to define benefit in patients with..:

Minari R ; Bonatti F ; Mazzaschi G...
info:eu-repo/semantics/altIdentifier/wos/WOS:000678127500001.  , 2021
 
?
14

Clinical Impact of COVID-19 Outbreak on Cancer Patients: A ..:

Buti S ; Perrone F ; Zielli T...
info:eu-repo/semantics/altIdentifier/wos/WOS:000707104000001.  , 2021
 
?
15

Predictive ability of a drug-based score in patients with a..:

Buti S ; Bersanelli M ; Perrone F...
info:eu-repo/semantics/altIdentifier/pmid/33934059.  , 2021
 
1-15